A major problem in solid-phase peptide synthesis (SPPS) is aggregation and poor solvation leading to incomplete deprotection and/or coupling steps, resulting in low crude purity peptides. 1 This ...
"The investment in our California facility represents a key milestone in our strategic growth and demonstrates an unwavering dedication to the domestic biopharma sector,” said Joerg Ahlgrimm, CEO of ...
Amide Technologies has raised $16.5 million in venture capital to help commercialize its peptide production process. The process was developed from 2011 to 2017 in the lab of the Massachusetts ...
Prominent players in the market include Bachem AG, PolyPeptide Group, CPC Scientific Inc., Lonza Group Ltd., CordenPharma International, and GenScript ROCKVILLE, MD, UNITED STATES, October 15, 2025 ...
Orocidin A/S, a unit of Nordicus Partners (OTCQB:NORD), said on Monday it has developed a cGMP-compliant manufacturing ...
India: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced ...
The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use ...
By combining advanced automation with deep scientific expertise, Syngene has built a robust, end-to-end platform that connects discovery to downstream development and manufacturing, strengthening its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback